There is a new and interesting press release from the University of Warwick's School of Engineering and Centre for Predictive Modeling 
drug discovery
The cancer drug business is quite a profitable one. A “high risk, high reward” proposition has been the narrative for those in research and development (R&D). Successes, marketing, patent protection and discovery cost money.
By any measure, malaria is one of the most ruthless threats t
In the world of drug research, the language can be a little
